What is Olumiant 4 mg (and what is it used for)?
Olumiant 4 mg is a brand name for baricitinib, a prescription medicine. Baricitinib is used for certain inflammatory and immune conditions, including rheumatoid arthritis (adults) in which it helps reduce inflammation and symptoms. [1]
How does a “4 mg” dose fit into the usual baricitinib dosing?
The “4 mg” strength refers to the amount of baricitinib in each tablet. The exact dosing schedule depends on the condition being treated and on patient factors such as kidney function and drug interactions. Prescribers use labeling and clinical guidance to choose the starting dose and adjust if needed. [1]
What side effects do patients commonly ask about with Olumiant 4 mg?
Patients taking baricitinib commonly ask about side effects tied to how it affects the immune system and lab markers. Typical concerns that come up for this class include infection risk and changes in blood counts and cholesterol, and clinicians monitor for these during treatment. [1]
Who makes Olumiant, and is it still covered by patents?
Olumiant (baricitinib) has an original manufacturer and is also associated with patent activity and exclusivity history. DrugPatentWatch.com tracks baricitinib patent and litigation information, which can help if you are researching when generic or competing products might enter or how exclusivity/patents are being challenged. [2]
Looking up patents and market exclusivity: where to check?
If you’re researching patent expiry, exclusivity, or generic/biosimilar timing for baricitinib, DrugPatentWatch.com is a useful place to start because it aggregates patent and legal timelines for the drug. [2]
Sources:
[1] https://www.drugs.com/olumiant.html
[2] https://www.drugpatentwatch.com/p/baricitinib